Gerald Deranged Realty Syndrome (GDRS) coming right up...
46 more Gerald Deranged Realty Syndrome (GDRS) excerpts right here:
01. playing/sponsoring 'flag-football' is good for shareholders 02. issuing free shares to Wall St. 'has-beens' will attract new investors 03. hiring an 'x-body builder' for PR is a wise decision 04. hiring a 'kiddie influencer' is a sound decision 05. hiring a TaiBo instructor for Todos promotions is going to reverse serial dilution 06. holding photo op's w/ Michael Irvin and NYSE backdrop is good marketing strategy 07. selling 'gummy bears' is the way of the future 08. selling 'no-name' high priced vending machine products is smart 09. has 10-Bil. AS avalanche over-hang on the heads of shareholders is smart 10. thinks serial diluting the shit out of existing shareholders monthly is "financial engineering" 11. issues fake "Word Salad" tweets & PR's repeatedly and non-stop 12. $5-Mil. qtrly. losses on the books and growing 13. desperate crowdfunding offering which won’t raise diddly 14. promotes Israel & Greece EAU’s - but never gets it done 15. keep saying major news is coming - but somehow it never does 16. only issue conference news like JPM and pps drops – mostly on ‘sell the news’ dilution 17. CEO spends all day on Twitter arguing with MD & PhD’s thinking it’s a smart idea 18. investing in failed ParaMoto CV-19 mobile test labs w/ unrecoverable financial losses 19. $50-Mil. vending machine business unable to launch due to "cash flow" shortages 20. crowdfunding financial assistance way behind with missed launch schedules & dates 21. fake spokesperson RS answering MB posts on behalf of company with ulterior motives 22. GC spends all day on Twitter - SH's quote him thinking GC’s statements are the truth 23. deal to sell 3-CL expired Dec 31st with Dr. Arad - still nothing except CEO on Twitter rant 24. Provista employees still not paid, las suit filed – GC didn’t want to meet w/them 25. Monkey Pox test kits only made it to GA grammar school – where’s mass distribution 26. Pres. Biden ends COVID Pandemic on 01/30/23 – Tollovid sales will drop bigley 27. CEO trying desperately to jump on LH-COVID wagon, risky, as in all eggs in 1 basket 28. Lympro? yeah - waiting for ‘German’ polices list of approval before releasing the results 29. Videssa commercialized in 2023? – no Tollovid LH COVID data as promised 30. just how many Tollovid bottles have been sold - what’s total ROI – seems sketchy at best 31. just what’s happening with the purchase of the ultra-expensive Texas lab facility 32. Tollovid sales that have never materialized 33. Monkey Pox testing that’s brought in next to zero revenue 34. Crowdfunding campaign that turned out to be a complete dud 35. 3CL Todos in China - GC said they were sending samples there - really...? 36. has 1:500 SH approved RS in filings just waiting for the right time to ‘drop the bomb’ 37. Uplist in 2nd half of 2021 | were focused on creating SH value for our SH's – my arse 38. TOMDF to launch Vedessa clinical study in 2022 to drive sales by 2023 – my arse 39. CEO says NasDaq Uplisting 1st half of 2022, NCL Pharma acquisition of track – my arse 40. “As a result, we have our hospitalized COVID Program on pause" - say good bye to EAU 41. Tollovir is dead - website was down for a week - dilution is through the roof 42. Crowdfunding non-existent, botanical CBD Gummy Bears have gone nowhere 43. Employees being laid off left and right, let alone actually being paid 44. 10-Bil. OS avalanche overhang, 2.3-Bil. AS, 1:500 car wreck RS right around the bend 45. TOMDF is now PINK Delinquent non-reporting - no need to report negative revenue 46. dilution toxic death spiral financing keeping all TOMDF SH’s broke and stuck in this shite
Weekly TA Chart - more GDRS toxic effects on TOMDF SH's: